{"id":8243,"date":"2021-12-16T12:26:48","date_gmt":"2021-12-16T17:26:48","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/categorie-superieure-abaloparatide-cas-247062-33-5-pour-un-taux-de-fracture-reduit-et-une-incidence-dhypercalcemie\/"},"modified":"2021-12-16T12:26:48","modified_gmt":"2021-12-16T17:26:48","slug":"categorie-superieure-abaloparatide-cas-247062-33-5-pour-un-taux-de-fracture-reduit-et-une-incidence-dhypercalcemie","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fr\/product\/categorie-superieure-abaloparatide-cas-247062-33-5-pour-un-taux-de-fracture-reduit-et-une-incidence-dhypercalcemie\/","title":{"rendered":"Cat\u00e9gorie sup\u00e9rieure Abaloparatide CAS 247062-33-5 pour un taux de fracture r\u00e9duit et une incidence d'hypercalc\u00e9mie"},"content":{"rendered":"

Cat\u00e9gorie sup\u00e9rieure Abaloparatide CAS 247062-33-5 pour un taux de fracture r\u00e9duit et une incidence d'hypercalc\u00e9mie<\/strong><\/h2>\n

Nom du produit\u00a0: Abaloparatide
\nS\u00e9quence\u00a0: H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu- Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-N-Me-Ala-Lys-Leu-His-Thr-Ala-NH2
\nSynonymes : Abaloparatide
\nCAS : 247062- 33-5
\nMF : C174H300N56O49
\nMW : 3960.5896
\nEINECS :
\nCat\u00e9gories de produits :
\nMol File : 247062-33-5.mol<\/p>\n

Abaloparatide, un activateur s\u00e9lectif du r\u00e9cepteur de l'hormone parathyro\u00efdienne (r\u00e9cepteur PTH1), a fait l'objet d'un d\u00e9veloppement clinique pour le traitement de l'ost\u00e9oporose chez les femmes m\u00e9nopaus\u00e9es \u00e0 haut risque de fracture en raison de sa bonne activit\u00e9 ost\u00e9og\u00e9nique, fabriqu\u00e9 \u00e0 partir d'abaloparatide.<\/p>\n

Index technique de Abaloparatide CAS 247062-33-5<\/strong>
\nApparence\u00a0: Poudre blanche
\nPuret\u00e9 (HPLC) \u226598,0%
\nContenu en ac\u00e9tate 5,0%~12,0%
\nContenu en eau \u22648,0%
\nContenu peptidique\u226580,0%
\nEmballage et transport\u00a0:
\nBasse temp\u00e9rature, emball\u00e9 sous vide, pr\u00e9cis au mg sur demande.<\/p>\n

Fonction et application de l'abaloparatide CAS 247062-33-5<\/strong>
\nAbaparatide, un peptide compos\u00e9 de 34 r\u00e9sidus d'acides amin\u00e9s, est un nouveau peptide li\u00e9 \u00e0 l'hormone parathyro\u00efdienne (PTHrP) d\u00e9velopp\u00e9 par RadiusHealth, qui est un activateur puissant et s\u00e9lectif du r\u00e9cepteur PTH-I pour augmenter le contenu min\u00e9ral osseux, la densit\u00e9 osseuse et la r\u00e9sistance osseuse et favoriser la formation osseuse , et a \u00e9t\u00e9 approuv\u00e9 pour la commercialisation par la FDA le 28 avril 2017 Chemicalbook 2017. approuv\u00e9 pour la commercialisation par la FDA le 28 avril 2017 sous le nom commercial Tymlos. L'abapatide est administr\u00e9 par voie sous-cutan\u00e9e pour le traitement de l'ost\u00e9oporose chez les femmes m\u00e9nopaus\u00e9es qui pr\u00e9sentent un risque de fracture ou qui n'ont pas r\u00e9pondu \u00e0 d'autres agents th\u00e9rapeutiques, et est efficace pour r\u00e9duire le taux de nouvelles fractures vert\u00e9brales et non vert\u00e9brales. L'abapatide est mieux \u00e0 m\u00eame de r\u00e9duire les taux de fractures et d'hypercalc\u00e9mie que le t\u00e9riparatide.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nom du produit : Abaloparatide
\nCAS : 247062-33-5
\nMF : C174H300N56O49
\nMW : 3960.5896
\nMol File : 247062-33-5.mol<\/p>\n","protected":false},"featured_media":2164,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[469],"product_tag":[1425],"class_list":{"0":"post-8243","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptide-dosteoporose","7":"product_tag-top-grade-abaloparatide-cas-247062-33-5-for-reduced-fracture-rate-and-hypercalcemia-incidence-fr","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product\/8243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/comments?post=8243"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media\/2164"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/media?parent=8243"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_brand?post=8243"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_cat?post=8243"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fr\/wp-json\/wp\/v2\/product_tag?post=8243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}